ACORN BIOVENTURES, L.P. 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:14 pm Purchase |
2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
ACORN BIOVENTURES, L.P. | 3,940,052 8.000% |
660,612 (+20.14%) |
Filing |
| 2024-11-14 12:12 pm Purchase |
2024-09-30 | 13G | Puma Biotechnology, Inc. PBYI |
ACORN BIOVENTURES, L.P. | 3,279,440 6.700% |
344,944 (+11.75%) |
Filing |
| 2024-02-06 3:54 pm Purchase |
2023-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
ACORN BIOVENTURES, L.P. | 2,934,496 6.200% |
194,561 (+7.10%) |
Filing |
| 2023-09-01 10:18 am Purchase |
2023-08-22 | 13G | Puma Biotechnology, Inc. PBYI |
ACORN BIOVENTURES, L.P. | 2,739,935 5.800% |
2,739,935 (New Position) |
Filing |